Cilostazol
Product Images NDC 16590-285

5 FDA label images from Stat Rx Usa Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cilostazol (NDC 16590-285). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cilostazol 100mg Label Image (Cilostazol 100mg Label)

Cilostazol 100mg Label Image (Cilostazol 100mg Label)
Label for Cilostazol 100 mg tablets, 60 count, distributed by STAT RX USA LLC in Gainesville, GA. The label states it is a generic for Pletal with NDC 16590-285-60. Manufactured by Corepharma LLC, Middlesex, NJ. The label includes a warning about grapefruit juice interaction and advises storing between 59-86°F. It also states the product is for Rx only and should be kept out of reach of children.*
FDA Label Image
FDA Label Image

Chemical Structure (Chem Structure)

Chemical Structure (Chem Structure)
Chemical structure of Cilostazol, showing its molecular framework with labeled rings, functional groups, and atom connectivity as depicted in the image.*
FDA Label Image

Graph (Graph 1)

Graph (Graph 1)
A line graph showing plasma concentration (ng/mL) over time (hours) for Cilostazol and two metabolites: 3,4-dehydro-cilostazol and 4'-trans-hydroxy-cilostazol. Cilostazol shows the highest concentrations, peaking around 2-4 hours, followed by 3,4-dehydro-cilostazol and then 4'-trans-hydroxy-cilostazol with lower levels throughout the 24-hour period.*
FDA Label Image

Graph 2 (Graph 2)

Graph 2 (Graph 2)
A bar graph illustrating the percent mean improvement in maximal walking distance at study end for eight randomized, double-blind, placebo-controlled clinical trials of CILOSTAZOL. The graph compares placebo, CILOSTAZOL 50 mg b.i.d., and CILOSTAZOL 100 mg b.i.d. treatments across trials of varying durations (12 to 24 weeks). Percent improvement is plotted on the vertical axis, and trial number along with sample sizes and durations are shown on the horizontal axis.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.